Phaseline

Companies › Calcilytix Therapeutics, Inc., a BridgeBio company

Calcilytix Therapeutics, Inc., a BridgeBio company: clinical trials, targets and expected readouts

1 active drug program in 3 registered trials: 2 Phase 3, 1 Phase 2; Metabolic and endocrine; next expected readout Jan 2028.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Encaleret
Calcimimetic agent; allosteric activator of the calcium-sensing receptor (CaSR)
CASRPhase 3Hypoparathyroidism; Autosomal Dominant Hypocalcemia (ADH); Autosomal Dominant Hypocalcemia Type 1 (ADH1)Jan 2028

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07805356EncaleretPhase 3HypoparathyroidismMetabolic and endocrineJan 2028
NCT07080385EncaleretPhase 2Autosomal Dominant Hypocalcemia Type 1 (ADH1)Metabolic and endocrineDec 2028
NCT05680818EncaleretPhase 3Autosomal Dominant Hypocalcemia (ADH)Metabolic and endocrineAug 2029

From the company's SEC filings

Cash and short-term investments of $1.5bn on 2026-09-30; operating cash outflow about $419m a year; runway about 44 months at that burn, to May 2030; 3 of 3 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Regulatory dates the company has stated

Agreements filed with the SEC (item 1.01), last two years

Targets

CASR (1)

Companies with the same targets

Amgen Shaanxi Micot Pharmaceutical Technology

Companies built like this

vTv Therapeutics Medicure BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd. Xintian Pharmaceutical Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.